화학공학소재연구정보센터
Korean Journal of Materials Research, Vol.20, No.3, 132-136, March, 2010
세포독성 평가를 통한 γ-Fe2O3 나노입자의 생체안정성 및 약물전달효율
Biostability and Drug Delivery Efficiency of γ-Fe2O3 Nano-particles by Cytotoxicity Evaluation
E-mail:
This study examined the biostability and drug delivery efficiency of g-Fe2O3 magnetic nanoparticles (GMNs) by cytotoxicity tests using various tumor cell lines and normal cell lines. The GMNs, approximately 20 nm in diameter, were prepared using a chemical coprecipitation technique, and coated with two surfactants to obtain a water-based product. The particle size of the GMNs loaded on hangamdan drugs (HGMNs) measured 20-50 nm in diameter. The characteristics of the particles were examined by X-ray diffraction (XRD), field emission scanning electron microscopy (FE-TEM) and Raman spectrometer. The Raman spectrum of the GMNs showed three broad bands at 274, 612 and 771 cm1. A 3-(4, 5- dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay showed that the GMNs were non-toxic against human brain cancer cells (SH-SY5Y, T98), human cervical cancer cells (Hela, Siha), human liver cancer cells (HepG2), breast cancer cells (MCF-7), colon cancer cells (CaCO2), human neural stem cells (F3), adult mencenchymal stem cells (B10), human kidney stem cells (HEK293 cell), human prostate cancer (Du 145, PC3) and normal human fibroblasts (HS 68) tested. However, HGMNs were cytotoxic at 69.99% against the DU145 prostate cancer cell, and at 34.37% in the Hela cell. These results indicate that the GMNs were biostable and the HGMNs served as effective drug delivery vehicles.
  1. Furumura K, Sugi H, Murakami Y, Asai H, US patent, 459814 (1986)
  2. Angeles V, Magdalena C, Alejandro GR, Macarena C, Sabino VV, Carlos JS, Maria PM, Rodolfo M, Nanotechnology, 20, 115103 (2009)
  3. Han JK, Kim HC, Hong WS, Choi SC, Korean J. Mater. Res., 18(7), 389 (2008)
  4. Morais PC, Garg VK, Oliveira AC, Silveira LB, Santos JG, Rodrigues MMA, Tedesco AC, Hyperfine Interact., 190, 87 (2009)
  5. Varshney M, Li Y, Biosensors Bioelectron., 22, 2408 (2007)
  6. Perez JM, Josephson L, Loughlin TO, Lgemann DH, Weissleder R, Nat. Biotechnol., 20, 816 (2002)
  7. Kim HK, Lee RY, Korean J. Mater. Res., 19(4), 192 (2009)
  8. Doyle PS, Bibette J, Bancaud A, Viovy J, Science, 295, 2237 (2002)
  9. Cao D, He P, Hu N, Analyst, 128, 1268 (2003)
  10. Kuckelhaus S, Reis SC, Carneiro MF, Tedesco AC, Oliveira DM, Lima ECD, Morais PC, Azevedo RB, Lacava ZGM, J. Magn. Magn. Mater., 2402, 272 (2004)
  11. Macaroff PP, Oliveira DM, Ribeiro KF, Lacava ZM, Lima ECD, Morais PC, Tedesco AC, J. Magn. Magn. Mater., 293, 293 (2005)
  12. Park SI, Kim J, Kim CO, J. Magn. Magn. Mater., 2340, 272 (2004)
  13. Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldofner N, Scholz R, Koch M, Lein M, Jung K, Loening SA, The prostate, 283, 1 (2005)
  14. Yoo HS, Cho CK, Hong MS, Integrative Cancer Therapies, 7, 182 (2008)
  15. Lee KJ, An JH, Shin JS, Kim DH, Kim C, Ozaki H, Koh JG, Nanotechnology, 18, 465201 (2007)
  16. Jacintho GVM, Corio P, Rubim JC, J. Electroanal. Chem., 603(1), 27 (2007)
  17. Morais PC, da Silva SW, Soler MAG, Buske N, J. Phys. Chem. A, 104(13), 2894 (2000)